Pulmonary Hypertension

This is when the blood pressure in the arteries that carry blood from your heart to your lungs gets too high. It's often caused by problems with the heart or lungs. It makes it harder for your heart to pump blood through your lungs.

Condition

What people with Pulmonary Hypertension report

Every report comes from a Lived member, sent anonymously.

Have you tried Viagra (Sildenafil) for Pulmonary Hypertension?

NameHow it went

About Pulmonary Hypertension

What It Is

Pulmonary hypertension (PH) is high blood pressure in the arteries that carry blood from the heart to the lungs. It is a different condition from ordinary high blood pressure, which is measured with an arm cuff and affects the arteries of the rest of the body. When the lung arteries become narrowed, stiffened or blocked, the right side of the heart has to pump harder to push blood through them. Over time that extra work can strain and weaken the right side of the heart. The most common symptom is shortness of breath, at first mainly during exercise or climbing stairs and later with less effort. Fatigue, chest pain or pressure, lightheadedness or fainting, and swelling of the legs, feet or abdomen can also develop. Because these symptoms overlap with many other heart and lung problems, people sometimes go years before the cause is found. PH is an umbrella term. Doctors sort it into five groups by cause: pulmonary arterial hypertension (PAH), a rare disease of the small lung arteries themselves; PH caused by disease of the left side of the heart, by far the most common type; PH caused by lung disease or low oxygen levels; PH caused by old blood clots that block the lung arteries (chronic thromboembolic pulmonary hypertension, or CTEPH); and PH with other or mixed causes. The group matters because treatment depends on it.

Causes & Risk Factors

Most PH develops as a consequence of another condition. Left-sided heart failure and heart valve disease raise pressure that backs up into the lungs. Lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease (scarring of the lung tissue) and sleep apnea lower oxygen levels, which causes the lung arteries to tighten. Blood clots in the lungs that never fully dissolve can leave lasting blockages. Sickle cell disease, sarcoidosis, liver disease and long-term kidney disease are among the other contributors. PAH has its own set of associations. In many cases no cause is found. Some cases run in families through inherited gene changes, and others are linked to connective tissue diseases such as scleroderma, HIV, chronic liver disease, congenital heart defects, or certain drugs and toxins, including methamphetamine and some medicines used for cancer. PAH is more common in women. The risk of PH rises with age, and it is usually diagnosed between ages 30 and 60. Having one of these conditions or exposures raises the chance of PH but does not mean it will develop. People with a known risk, such as scleroderma or a past lung clot, may be offered screening.

How It's Diagnosed

Diagnosis usually starts with a careful history and examination, then an echocardiogram (an ultrasound of the heart). The echocardiogram estimates the pressure in the lung arteries and shows whether the right side of the heart is enlarged or straining. It can make PH likely or unlikely, but it cannot confirm it. Confirmation comes from right heart catheterization, in which a thin tube is guided through a vein into the right side of the heart and the lung artery to measure pressures directly. Normal average pressure in the lung artery at rest is roughly 20 millimeters of mercury (mm Hg) or lower. Under current guidelines, PH means an average pressure above 20 mm Hg at rest; older definitions used 25 mm Hg, so older reports may use that number. The same test measures pressure on the left side of the heart and how much resistance the lung vessels create, which helps show whether the problem starts in the lung arteries themselves or is backing up from the left side of the heart. Because treatment depends on the cause, other tests look for it: blood tests, an electrocardiogram (ECG), breathing tests, chest imaging, sleep studies, and a ventilation/perfusion (V/Q) lung scan, which is the preferred way to look for old clots. A six-minute walk test measures how far someone can walk and is used to track how the condition responds over time. When PAH or CTEPH is suspected, referral to a specialized pulmonary hypertension center is recommended.

Treatment Options

Treatment depends on which group of PH someone has. There is usually no cure, but treatment can ease symptoms, improve how far and how comfortably someone can move, and slow the disease. For PH caused by left heart disease or lung disease, which together make up most cases, the main treatment is the underlying condition: heart failure medicines or valve repair, oxygen when levels are low, treatment of sleep apnea, and pulmonary rehabilitation (a supervised exercise and education program). The medicines designed for PAH have not been shown to help PH from left heart disease and are generally not recommended for it. In most lung-disease PH they can worsen oxygen levels; one exception is inhaled treprostinil, which is approved for PH linked to interstitial lung disease. PAH has a range of targeted medicines that relax and help remodel the narrowed lung arteries. They include endothelin receptor antagonists such as macitentan (Opsumit), phosphodiesterase-5 inhibitors such as sildenafil (Revatio, the same ingredient as Viagra at a different dose), riociguat (Adempas), medicines that act on the prostacyclin pathway (given as pills, inhaled, or by continuous infusion through a small pump), and sotatercept (Winrevair), a newer injection given every three weeks that targets the overgrowth of cells in the artery walls. Many people start on two medicines together because combination treatment slows worsening better than one. Several of these medicines can harm a developing baby, so a pregnancy test before starting and reliable contraception during treatment and for a period after stopping are required. Sildenafil and riociguat must never be combined with nitrate heart medicines such as nitroglycerin, or with each other, because blood pressure can drop dangerously. Sotatercept requires regular blood tests because it can raise red blood cell levels and lower platelets. CTEPH is the one form that can sometimes be treated at its source. Pulmonary endarterectomy is surgery that removes the scarred clot material from the lung arteries; for people who cannot have surgery or still have PH after it, balloon pulmonary angioplasty (widening the vessels with a catheter balloon) or riociguat may help. People with CTEPH take blood thinners long term to prevent new clots. Across groups, diuretics (water pills) help control fluid buildup, and oxygen is used when levels are low. For severe disease that does not respond to medicine, a lung or heart-lung transplant may be considered.

What to Expect

PH is usually a long-term condition, and its course varies widely with the cause, how advanced it is when found and how well it responds to treatment. Some people with PH from heart or lung disease are affected mainly by that underlying illness. PAH, without treatment, tends to progress toward right heart failure; modern combination treatment has improved how long and how well people live, though outcomes still differ considerably from person to person. Daily life often involves pacing activity, staying physically active at a level the care team recommends, limiting salt and watching for fluid gain, and, for some, using oxygen or managing an infusion pump. High altitudes and air travel can lower oxygen levels, so trips are worth planning with the care team. Yearly flu shots and pneumococcal vaccines are usually recommended because lung infections can hit harder. Pregnancy carries a high risk of serious, sometimes life-threatening complications for both parent and baby with PH, so contraception and any plans for pregnancy are an important conversation early on. Follow-up visits track symptoms, walking distance, blood tests and heart imaging, and sometimes repeat catheterization, to judge whether treatment is working and whether to add or change medicines. Support groups, counseling and pulmonary rehabilitation can help with the physical and emotional load of a chronic illness.

When to Seek Help

See a clinician if shortness of breath, tiredness or reduced exercise tolerance develops without a clear explanation, especially if you have scleroderma, a past blood clot in the lungs, liver disease, HIV or a family history of PAH. If you already have PH, contact your care team without waiting for the next scheduled visit if you become breathless with less activity than usual, notice new or increasing swelling or quick weight gain, have dizzy spells or faint, or cough up blood. If you use a continuous infusion and the pump or line stops or fails, restart it right away with your backup pump and supplies and call your PH team's 24-hour number at once, because even a brief interruption can cause rapid, dangerous worsening. If the infusion cannot be restarted quickly, call 911. Call 911 for chest pain or shortness of breath that comes on suddenly, is severe, or does not ease with rest, since it can signal a blood clot in the lungs or a heart attack.

Questions to Ask Your Doctor

  1. 1.Which group of pulmonary hypertension do I have, and how sure are we about the cause?
  2. 2.Should I be seen at a specialized pulmonary hypertension center?
  3. 3.What are the goals of my treatment, and which tests will show whether it is working?
  4. 4.What level of exercise, travel and altitude is safe for me?
  5. 5.How do my medicines affect pregnancy and contraception, and what should I know if I plan to have children?

Last reviewed • Oct 2026

Educational content, not medical advice.